Chairman of the Board

Peter serves as Chairman of Exostatics.

He is an MD specialised in Internal medicine and Emergency medicine and owns a PhD on Innovative Multimodal Imaging in Cardiology. He built an extended carrier in the pharmaceutical industry, with a long-standing experience both in the clinical and research fields, managing the commercialization of multiple new therapeutics for cardiovascular and metabolic diseases, as well as for anticoagulation, including warfarin and NOACs. He also launched several first-in-class-first-in-human compounds.

Currently, he is Head of Medical Innovation in AstraZeneca Italy. Previously he as Head of Innovation in Cardiovascular, Renal and Metabolism Biopharmaceutical at the AstraZeneca Global HQ in Cambridge (UK). Thanks to these roles, he is able to consult in different capacity the dynamic ecosystem of start-ups in healthcare. Peter is also a Partner at HealthTech180, an advisory and consulting healthcare platform focusing on Technology Transfer and Venture Building, and Chairman of the Board at Hemostatics, a healthcare startup which develops a novel anti-hemorrhagic drug.

Peter is a passionate clinical researcher and business leader who possesses a strong corporate entrepreneurial footprint. He is engaged in identifying and drive effective, individualised and scalable solutions helping people succeed in living a healthy life, preventing epidemic-size chronic diseases that share common pathways and removable behaviour-related risk factors.

He is the co-author on a number of manuscripts published in peer-review scientific journals, mainly in the field of cardiology, resuscitation, diabetes, magnetocardiography, real-world evidence and health economic models.